I got so excited about Carbios because of this article that I started digging a bit deeper.
The article explains how researchers at the University of Portsmouth discovered a new super-enzyme that breaks down plastic into recyclable polymers at room temperature. Carbios had previously developed a similar enzyme, but that one required a temperature of 70 degrees Celsius to work. The article also suggested a collaboration between Carbios and the University of Portsmouth researchers. Quoted from the article:
The new super-enzyme works at room temperature, and McGeehan said combining different approaches could speed progress towards commercial use: “If we can make better, faster enzymes by linking them together and provide them to companies like Carbios, and work in partnership, we could start doing this within the next year or two.”
Facts about Carbios:
Carbios was founded by Truffle Capital and started operations in 2011, headquartered in France. Market Cap approx. €300m, but operates at a loss (likely for several years). Collaborates with L’Oreal, Novozymes, Nestle, Pepsico, and several research institutions, among others. Of these, at least L’Oreal is also involved as a financier in Carbios with a 6.05% stake. Other financiers include Michelin Ventures (4.55% stake) and Truffle Capital with an 8.26% stake. The stock is liquid, as 73.04% is on the open market. Truffle Capital states it is “the only European Fund to support its innovations from creation to commercial success” and collaborates with 50 top European universities. In the summer, Carbios received an additional €27 million in funding, which will allow them to operate for at least the next two years. Carbios is covered by Kepler Cheuvreux, Bryan, Garnier & Co, Gilbert Dupont, and Edison Investment Research.
So, the company’s financial background is solid for at least a couple of years.
Megatrend:
- The world is full of plastic and textiles that cannot be recycled. The collapse of ecosystems has already partially occurred due to the large amount of plastics in the oceans and nature. This, alongside climate change, is the greatest ecological threat to humans, animals, and plants. Humans have also been found to even breathe microplastics into their lungs.
Growth drivers:
- France is striving to move its society towards a more sustainable direction (In-Depth - Lexology), which is reflected in support for hydrogen technology and biotechnology, among other areas.
- The EU is pursuing the same agenda.
- Responsible investing.
- Collaboration with Novozymes provides a solid foundation.
Risks:
- There is no evidence of commercial operations and their sustainability. New, centralized facilities will only be completed in September 2021, at which point they will be able to demonstrate the commercial viability.
- They aim to sell the first licenses by 2023, meaning long-term involvement is required.
